Summary
In conclusion, uncomplicated type A intramural hematoma patients with
type 2 diabetes mellitus (receiving the “wait-and-watch strategy” and
tight glycemic control) may have a lower aorta-related mortality, rates
of aorta-related adverse events and reinterventions during the follow-up
period than patients without diabetes mellitus. Moreover, in patients
without diabetes mellitus, it seems logical to recommend prophylactic
replacement of an aortic wall that presents the intramural hemorrhage,
since the rates of aorta-related adverse events and reinterventions
during the follow-up period were found to be obviously higher than those
in patients with diabetes mellitus.